Clinical trial
An Open-Label Multi-Center Study of ATI-5923 for Anticoagulation in Patients With Atrial Fibrillation
NCT00431782 is registered in ClinicalTrials.gov with ARYx Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Multi-Center Study of ATI-5923 for Anticoagulation in Patients With Atrial Fibrillation
- Lead sponsor
- ARYx Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- October 31, 2007
- Enrollment
- 60 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.